Clinical trial · Observational
Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer
Social Anxiety and Avoidance in Head and Neck Cancer Patients
NCT00483639CI-TRIAL-00009729completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Patients who undergo treatment for head and neck cancer may become anxious and avoid contact with other people. Learning how cancer treatment may cause anxiety in patients with head and neck cancer may help improve the quality of life in these patients. PURPOSE: This clinical trial is studying anxiety and avoidance of others in patients previously treated for head and neck cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety Disorder | — | UNRESOLVED | — |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Functional Assessment of Cancer Therapy-General (FACT-G) | Other | — | UNRESOLVED |
| Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory | Other | — | UNRESOLVED |
| management of therapy complications | Procedure | — | UNRESOLVED |
| Medical chart review | Other | — | UNRESOLVED |
| Structured Clinical Interview for the Diagnostic and Statistical Manual-IV SCID | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Level of social anxiety and avoidance in HNC patients post-treatment
- timeFrame
- at study entry, day 1
- description
- Measured by the Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory, containing 24 items with each item separately rated for fear as 0 (none), 1 (mild), 2 (moderate) to 3 (severe)and for avoidance behavior as 0 (never), 1 (occasionally), 2 (often), to 3 (usually). Scores are summed with lower values indicating lower levels of social anxiety and avoidance.
Secondary outcomes (3)
- measure
- Relationship between pre-cancer psychiatric diagnosis and post-treatment social anxiety and avoidance
- timeFrame
- at study entry
- description
- Assessed using the Structured Clinical Interview for the Diagnostic and Statistical Manual-IV SCID lifetime diagnostic status (pre-cancer diagnosis) and related to the outcome for social anxiety measures. The SCID does not involve a specific scoring of responses. Trained interviewers ask questions that may involve yes/no answers or more detailed explanations. They make their diagnoses based on their experience and training. For this outcome, interviews results will be compared to and contrasted with scores on the Liebowitz Social Anxiety Scale and Social Phobia and Anxiety Inventory.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 70 Years
Show eligibility criteria text
PATIENT CHARACTERISTICS: * Diagnosis of 1 of the following: * Head and neck cancer * Lung cancer (control group) * Must have received treatment for head and neck cancer or lung cancer within the past 5 years PATIENT CHARACTERISTICS: * Able to speak and read English to answer surveys, interviews, and questionnaires PRIOR CONCURRENT THERAPY: * See Disease Characteristics
References
Publications (0)
Data not yet available
No reference posted for this study.